Overall, these results provide evidence that RAB3A knockdown increases the nuclear localization of BAG6-EP300, which further acetylates p53 and Rb proteins, thereby contributing to the suppression of NSCLC progression. Here, EP300 is linked to non-small cell lung carcinoma.